has been cited by the following article(s):
[1]
|
Effects of
Xeroderma pigmentosum group C
polymorphism on the likelihood of prostate cancer
Journal of Clinical Laboratory Analysis,
2020
DOI:10.1002/jcla.23403
|
|
|
[2]
|
XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma
Medicine,
2020
DOI:10.1097/MD.0000000000021160
|
|
|
[3]
|
Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer
Journal of Clinical Laboratory Analysis,
2020
DOI:10.1002/jcla.23403
|
|
|
[4]
|
XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma
Medicine,
2020
DOI:10.1097/MD.0000000000021160
|
|
|